The molecular pathophysiology of immune thrombocytopenia: the new frontier
Blood Vessels, Thrombosis & Hemostasis · 2026-11 · 3 (4) · 100218
DOI: 10.1016/j.bvth.2026.100218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2026-11. Verfasst von John W. Semple und 3 weiteren Autor:innen. Die Arbeit nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Research Council, Alfred Österlunds Stiftelse, Stichting Sanquin Bloedvoorziening.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Swedish Research Council
- Alfred Österlunds Stiftelse
- Stichting Sanquin Bloedvoorziening
Zitieren
APA
Semple, J. W., Audia, S., Mahévas, M., & Kapur, R. (2026). The molecular pathophysiology of immune thrombocytopenia: the new frontier. Blood Vessels, Thrombosis & Hemostasis, 3(4), 100218. https://doi.org/10.1016/j.bvth.2026.100218
Vancouver
Semple JW, Audia S, Mahévas M, Kapur R. The molecular pathophysiology of immune thrombocytopenia: the new frontier. Blood Vessels, Thrombosis & Hemostasis. 2026;3(4):100218. doi:10.1016/j.bvth.2026.100218
BibTeX
@article{Semple2026,
author = {Semple, John W. and Audia, Sylvain and Mahévas, Matthieu and Kapur, Rick},
title = {The molecular pathophysiology of immune thrombocytopenia: the new frontier},
journal = {Blood Vessels, Thrombosis & Hemostasis},
year = {2026},
volume = {3},
number = {4},
pages = {100218},
doi = {10.1016/j.bvth.2026.100218}
}
EUVIMED